Pulse Biosciences (PLSE) Change in Receivables (2021 - 2025)
Pulse Biosciences has reported Change in Receivables over the past 5 years, most recently at $259000.0 for Q4 2025.
- Quarterly results put Change in Receivables at $259000.0 for Q4 2025, up 3600.0% from a year ago — trailing twelve months through Dec 2025 was $274000.0 (changed N/A YoY), and the annual figure for FY2025 was $274000.0, changed.
- Change in Receivables for Q4 2025 was $259000.0 at Pulse Biosciences, up from $1000.0 in the prior quarter.
- Over the last five years, Change in Receivables for PLSE hit a ceiling of $259000.0 in Q4 2025 and a floor of -$114000.0 in Q4 2022.
- Median Change in Receivables over the past 5 years was $3000.0 (2023), compared with a mean of $8250.0.
- Biggest five-year swings in Change in Receivables: crashed 1088.89% in 2023 and later surged 3600.0% in 2025.
- Pulse Biosciences' Change in Receivables stood at -$11000.0 in 2021, then plummeted by 936.36% to -$114000.0 in 2022, then skyrocketed by 104.39% to $5000.0 in 2023, then soared by 40.0% to $7000.0 in 2024, then surged by 3600.0% to $259000.0 in 2025.
- The last three reported values for Change in Receivables were $259000.0 (Q4 2025), $1000.0 (Q3 2025), and $7000.0 (Q2 2025) per Business Quant data.